i believe this is in reference to BP wanting a once a month version of LL for a combo with their own once a month drug in order to gain (first time) approval. im assuming you cant have a new approved combo therapy where the one (currently unapproved for anything) drug is once a week and the other current drug is once a month. of course once LL is approved for anything on a mono therapy, its the off label use for the other 30+ indications that will start happening for sure. and at whatever doses and frequency that works best, forget "convenience".

BP is making these demands for a combo therapy but for us on the sidelines it seems ridiculous to not use LL once a week if they know it works. especially if im dying. i will gladly be inconvenienced.

same thing for the PrEP demands by the FDA...if LL works, and works better, and has zero side effects, ill gladly be inconvenienced once a week. seems like the patient demand side is being catered to like a bunch of children who want the crust cut off of their peanut butter and jelly sandwiches. especially when insulin is shot into the body daily by millions of people. CYDY is clearly getting bullied here.

but what do i know.

Quote:

---

Right My69. If leronlimab gives you an additional number of years or remission a weekly injection isn’t going to seem inconvenient.

Investors Hangout: https://investorshangout.com/post/newpost/605...z8cJVdD5lA

---